Mouse IgG2a, kappa Isotype Control antibody (MOPC-173)

Structure of Mouse IgG2a, kappa Isotype Control antibody (MOPC-173)

Mouse IgG2a, kappa Isotype Control antibody (MOPC-173) is a monoclonal antibody that belongs to the immunoglobulin G (IgG) subclass 2a and has kappa light chain. It is a mouse-derived antibody that is commonly used as an isotype control in immunological research. The antibody is produced by hybridoma cells generated by the fusion of mouse myeloma cells with splenocytes from mice immunized with a non-specific antigen.

The structure of Mouse IgG2a, kappa Isotype Control antibody (MOPC-173) is similar to other IgG antibodies and consists of two heavy chains and two light chains. The heavy chains are composed of four constant domains (CH1, CH2, CH3, and CH4) and one variable domain (VH), while the light chains consist of one constant domain (CL) and one variable domain (VL). The variable domains of both heavy and light chains are responsible for binding to specific antigens.

Activity of Mouse IgG2a, kappa Isotype Control antibody (MOPC-173)

Mouse IgG2a, kappa Isotype Control antibody (MOPC-173) does not bind to any specific antigen and therefore, does not have any biological activity. Its main purpose is to serve as a control in experiments involving the use of monoclonal antibodies. This is because it has the same structure and isotype as other monoclonal antibodies, but lacks specificity for any particular antigen. This allows researchers to determine the background levels of non-specific binding and ensure the accuracy of their experimental results.

In addition, Mouse IgG2a, kappa Isotype Control antibody (MOPC-173) can also be used as a negative control in flow cytometry experiments. It helps to distinguish between specific and non-specific binding of fluorescently labeled antibodies, thus providing more accurate results.

Application of Mouse IgG2a, kappa Isotype Control antibody (MOPC-173)

Mouse IgG2a, kappa Isotype Control antibody (MOPC-173) has a wide range of applications in immunological research. Its main use is as an isotype control in experiments involving monoclonal antibodies. It is particularly useful in studies involving the use of multiple monoclonal antibodies, as it ensures that any observed effects are due to the specific antibody being tested and not due to non-specific interactions.

Moreover, Mouse IgG2a, kappa Isotype Control antibody (MOPC-173) is also used as a negative control in flow cytometry experiments, as mentioned earlier. It is essential for accurate interpretation of flow cytometry data, as it helps to distinguish between specific and non-specific binding of fluorescently labeled antibodies.

Furthermore, Mouse IgG2a, kappa Isotype Control antibody (MOPC-173) can also be used as a therapeutic target in certain diseases. It has been shown to have anti-tumor activity in mouse models and has been used in combination with other antibodies for the treatment of cancer. However, more research is needed to fully understand its potential as a therapeutic target.

In conclusion, Mouse IgG2a, kappa Isotype Control antibody (MOPC-173) is a non-specific antibody commonly used as an isotype control in immunological research. Its structure, activity, and application make it an essential tool for accurate and reliable experimental results. With its wide range of uses, this antibody continues to play a crucial role in advancing our understanding of the immune system and its role in diseases.